NTR-1011

N/A

Report date: 2025/11/24 20:00:49
NME

Base Information

Drug NameNTR-1011
Drug Alias NameNTR1011NTR-1011
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeutrolis Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeutrolis Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A